Fever, headache, nausea, asthenia, hypotension, increased alanine aminotransferase,increased aspartate aminotransferase, increased total bilirubin, and disseminated intravascular coagulation (DIC). The manifestations of CRS after treatment with BLINCYTO overlap with those of infusion reactions, capillary leak syndrome (CLS), and hemophagocytic histiocytosis/macrophage activation syndrome (MAS). This evidence concerns the gene GPT and Disseminated intravascular coagulation.